However, no evidence is available for the engineering of an entire metabolic pathway (recombinant human GAMT plus recombinant MAT) as a potential strategy to treat patients with GAMT deficiency, capable of reducing the high toxic levels of GAA and restoring proper Cr levels in blood and tissue. Here, GAMT is linked to hyperinsulinemic hypoglycemia, familial, 4.